What does Natera, Inc. do?

Jun 22 2025 06:38 PM IST
share
Share Via
Natera, Inc. is a mid-cap diagnostics company specializing in genetic testing services, with recent net sales of $502 million and a net loss of $67 million. The company has a market cap of approximately $22.88 billion and does not pay dividends.
Overview:
Natera, Inc. is a diagnostics company engaged in the discovery, development, and commercialization of genetic testing services within the Pharmaceuticals & Biotechnology industry, categorized as a mid-cap company.

Financial Snapshot:
- Most recent Net Sales: 502 Million (Quarterly Results - Mar 2025)
- Most recent Net Profit: -67 Million (Quarterly Results - Mar 2025)
- Market cap: USD 22,878.38 Million (Mid Cap)

Key Metrics:
- P/E: NA (Loss Making)
- Industry P/E: NA
- Dividend Yield: 0.00%
- Debt Equity: -0.73
- Return on Equity: -15.31%
- Price to Book: 18.46

Contact Details:
- Address: 201 Industrial Rd Ste 410, SAN CARLOS CA: 94070-2396
- Tel: ['1 650 2499090', '1 650 2499091']
- Fax: 1 302 6745266
- Website: http://www.natera.com
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News